Tirzepatide also lowered 24-hour diastolic blood pressure (the bottom number) compared to a placebo
It anchors a broader, supervised plan that also addresses nutrition, activity, and the metabolic factors driving your results
appetite suppression becomes noticeable Weeks 9-16: Gradual escalation toward 1.7-2.4 mg target dose Months 3-6: Significant weight loss becomes evident
This can help you notice patterns and identify triggers
Dr Hurtado Andrade added: Next, we plan to test these observations in a randomised clinical trial and determine if benefits extend beyond weight loss, specifically, whether hormone therapy also enhances the effects of these medications on cardiometabolic measures
Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycaemic control in adults with type 2 diabetes mellitus